# Eikonizo Therapeutics, Inc. — Form D

Eikonizo Therapeutics, Inc. of BEVERLY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-16. The offering totals $841K, of which $371K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2018-05-16
- Form: D
- Accession: 0001735756-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $841K
- Amount sold: $371K
- Remaining: $470K
- Investors: 1
- Date of first sale: 2018-05-15
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-312582

## Issuer

- Name: Eikonizo Therapeutics, Inc.
- CIK: 0001735756
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 996 HALE STREET, BEVERLY, MA, 01915
- Phone: 617-308-4405

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kevin Kinsella | Director | Beverly, MA |
| Janice Kranz | Director | Beverly, MA |
| William Shaw | Director | Grand Cayman, E9 |
| Stacie Weninger | Director | Watertown, MA |
| Janice Kranz | Executive Officer | Beverly, MA |
| William Shaw | Executive Officer | Grand Cayman, E9 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-04-17](https://search.stillhousedata.com/formd/0001735756-18-000001) | D | $2.0M | $2.0M |

## More

- [CIK 1735756 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1735756&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001735756-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.